|
|
|
Insider
Information: |
Andreotti Lamberto |
Relationship: |
|
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
1,011,868 |
|
Indirect Shares
|
241,273 |
|
|
Direct
Value |
$40,817,011 |
|
|
Indirect Value
|
$9,863,240 |
|
|
Total
Shares |
1,253,141 |
|
|
Total
Value |
$50,680,251 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
14.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
Director |
2017-04-07 |
935,571 |
2017-04-07 |
241,273 |
Premium* |
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-12-23 |
19,609 |
2009-02-17 |
0 |
Premium* |
|
DuPont de Nemours Inc |
DD |
Director |
2017-08-31 |
0 |
2012-08-02 |
0 |
Premium* |
|
Dowdupont Inc. |
DWDP |
Director |
2019-05-21 |
22,231 |
|
0 |
Premium* |
|
Corteva, Inc. |
CTVA |
|
2024-04-26 |
34,457 |
2019-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
218 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 9
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CTVA |
Corteva, Inc. |
|
|
2024-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,100 |
34,457 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2010-09-20 |
4 |
D |
$27.81 |
$548,580 |
D/D |
(19,726) |
196,089 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(54,918) |
257,171 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
116,000 |
312,089 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-01 |
4/A |
D |
$25.58 |
$1,497,709 |
D/D |
(58,550) |
253,539 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,348 |
269,887 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
598 |
270,485 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,553) |
261,932 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-04 |
4 |
D |
$26.43 |
$99,430 |
D/D |
(3,762) |
265,622 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,452 |
269,384 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,600 |
272,222 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-06 |
4 |
D |
$26.43 |
$88,065 |
D/D |
(3,332) |
268,890 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-03-07 |
4 |
D |
$26.31 |
$122,184 |
D/D |
(4,644) |
264,246 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,893 |
280,128 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-05-04 |
4 |
D |
$28.71 |
$230,139 |
D/D |
(8,016) |
272,112 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2011-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,989 |
278,235 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,530 |
305,642 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,083 |
314,725 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-03-01 |
4 |
D |
$32.64 |
$603,807 |
D/D |
(18,499) |
296,226 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,240 |
317,815 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,349 |
312,575 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-03-02 |
4 |
D |
$32.59 |
$355,101 |
D/D |
(10,896) |
306,919 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,344 |
317,263 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-03-03 |
4 |
D |
$32.59 |
$170,152 |
D/D |
(5,221) |
312,042 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2012-03-04 |
4 |
D |
$32.59 |
$122,604 |
D/D |
(3,762) |
315,733 |
0 |
- |
|
218 Records found
|
|
Page 1 of 9 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|